NetScientific is a transatlantic healthcare IP commercialisation company. The Group has this morning released full year results to 31 December 2018, which illustrate a loss from continuing operations of £4.0m; these excluding Wanda and Vortex which were sold on 22nd March 2019. Group cash as at 30 April 2019 stood at £3.0m (31 December 2018 £2.9m), of which £1.7m was held in the parent company.
22 May 2019
First Light
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
First Light
NetScientific plc (NSCI:LON) | 63.0 0 0.0% | Mkt Cap: 15.1m
- Published:
22 May 2019 -
Author:
John Cummins -
Pages:
4
NetScientific is a transatlantic healthcare IP commercialisation company. The Group has this morning released full year results to 31 December 2018, which illustrate a loss from continuing operations of £4.0m; these excluding Wanda and Vortex which were sold on 22nd March 2019. Group cash as at 30 April 2019 stood at £3.0m (31 December 2018 £2.9m), of which £1.7m was held in the parent company.